Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Altria's Oral Nicotine Pouch Product Is Going Nationwide. Is the Stock a Buy in 2026?
↗
Today 8:25 EDT
Via
The Motley Fool
Tickers
MO
Exposures
Product Safety
Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
Today 7:00 EDT
Via
Newsfile
Tickers
PHIO
Exposures
Product Safety
CCHR: Time to End the Psychotropic Pill Epidemic – National Adverse Drug Event Awareness Day Exposes America’s Hidden Medication Crisis
Today 6:00 EDT
Via
Send2Press
Topics
Death
Exposures
Death
Product Safety
New Book It’s Raining Fish by Gloria Joanne Kramer-Gordon, Ed.D. Explores Cultural Identity and Classroom Diversity
March 27, 2026
Via
GlobePRwire
Topics
Product Recall
Exposures
Legal
Product Safety
Psilocybin-Assisted Therapy: A Modern Approach to Mental Health Innovation
Today 5:23 EDT
Via
BusinesNews Wire
Exposures
Product Safety
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
March 28, 2026
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
QURE
Exposures
Financial
Legal
Product Safety
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
March 28, 2026
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
QURE
Exposures
Financial
Legal
Product Safety
SLNO DEADLINE FOR LEADERSHIP is May 5, 2026 in a Securities Fraud Lawsuit Against Soleno Therapeutics, Inc. (NASDAQ: SLNO) - Contact Kaplan Fox
March 28, 2026
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
SLNO
Exposures
Financial
Legal
Product Safety
SLNO DEADLINE FOR LEADERSHIP is May 5, 2026 in a Securities Fraud Lawsuit Against Soleno Therapeutics, Inc. (NASDAQ: SLNO) - Contact Kaplan Fox
March 28, 2026
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
SLNO
Exposures
Financial
Legal
Product Safety
Deadline is April 21, 2026 to Lead in Securities Class Action Against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Contact Kaplan Fox
March 28, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
CORT
Exposures
Financial
Legal
Product Safety
Deadline is April 21, 2026 to Lead in Securities Class Action Against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Contact Kaplan Fox
March 28, 2026
Via
TheNewswire.com
Topics
Lawsuit
Tickers
CORT
Exposures
Financial
Legal
Product Safety
Australian Personal Alarm Company Cuts Elderly Care Costs with Subscription-Free Safety Device
March 27, 2026
Via
AB Newswire
Topics
Product Recall
Tickers
ASX:TLS
Exposures
Legal
Product Safety
Why Corcept Therapeutics Zoomed Nearly 9% Higher This Week
↗
March 27, 2026
Via
The Motley Fool
Tickers
CORT
Exposures
Product Safety
Eli Lilly Shares Slip Despite Positive Eczema Trial Results: Why the Market Reacted Coolly
March 27, 2026
Via
MarketMinute
Tickers
ABBV
APGE
HSBC
LLY
NVO
REGN
Exposures
Product Safety
AstraZeneca (AZN) Shares Rally After Breakthrough Chronic Lung Disease Trial Results
March 27, 2026
Via
MarketMinute
Topics
Intellectual Property
Tickers
AZN
GSK
REGN
RHHBY
SNY
Exposures
Intellectual Property
Product Safety
Professional OEM Manufacturing of Global Coffee Mugs
March 27, 2026
Via
AB Newswire
Topics
Economy
Exposures
Product Safety
Supply Chain
Google Just Unveiled TurboQuant: Should You Sell Sandisk Stock Now?
March 27, 2026
Via
Barchart.com
Topics
Artificial Intelligence
Product Recall
Tickers
GOOG
GOOGL
Exposures
Artificial Intelligence
Legal
Product Safety
Bridging the Gap in NSCLC Therapy: The Rise of Antibody-Drug Conjugates
March 27, 2026
Via
AB Newswire
Exposures
Product Safety
DBV Technologies Sets Stage For 'Swift' Success As Breakthrough Peanut Patch Nears FDA Submission
↗
March 27, 2026
Via
Benzinga
Exposures
Product Safety
CORCEPT THERAPEUTICS DEADLINE FOR LEADERSHIP is April 21, 2026 in a Securities Fraud Lawsuit - Investors Encouraged to Contact Kaplan Fox
March 27, 2026
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
CORT
Exposures
Financial
Legal
Product Safety
CORCEPT THERAPEUTICS DEADLINE FOR LEADERSHIP is April 21, 2026 in a Securities Fraud Lawsuit - Investors Encouraged to Contact Kaplan Fox
March 27, 2026
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
CORT
Exposures
Financial
Legal
Product Safety
Kaplan Fox Reminds Investors of Soleno Therapeutics, Inc. (SLNO) to a Class Action Deadline on May 5, 2026
March 27, 2026
Via
TheNewswire.com
Topics
Lawsuit
Tickers
SLNO
Exposures
Financial
Legal
Product Safety
Kaplan Fox Reminds Investors of Soleno Therapeutics, Inc. (SLNO) to a Class Action Deadline on May 5, 2026
March 27, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
SLNO
Exposures
Financial
Legal
Product Safety
GlucoTrack Stock Gains As Data Backs FDA Filing Plans For Glucose Monitoring Tech
↗
March 27, 2026
Via
Benzinga
Exposures
Product Safety
InvestorNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Receives FDA Clearance For STAR-001 Pediatric CNS Cancer Trial
March 27, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Tickers
LTRN
Exposures
Artificial Intelligence
Product Safety
Why Is Rocket Pharma Stock Soaring Friday?
↗
March 27, 2026
Via
Benzinga
Exposures
Product Safety
Novo Nordisk Wins FDA Nod For First-Ever Weekly Basal Insulin
↗
March 27, 2026
Via
Benzinga
Exposures
Product Safety
Medicus Pharma (MDCX): A Small-Cap Biotech Making Moves in 2026
March 27, 2026
Via
AB Newswire
Tickers
ARM
MDCX
Exposures
Product Safety
OS Therapies Granted Meetings with U.S. FDA, U.K. MHRA, EMA and Australian Therapeutic Goods Administration to Review Global Confirmatory Phase 3 Trial for OST-HER2 in Metastatic Osteosarcoma
March 27, 2026
Via
Newsfile
Tickers
OSTX
Exposures
Product Safety
What to Expect From Edwards Lifesciences' Next Quarterly Earnings Report
March 27, 2026
Via
Barchart.com
Topics
ETFs
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.